Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors

OXFORD, England, July 7, 2010 - Elsevier is pleased to announce the appointment of prominent new
Editors-in-Chief to three key endocrinology titles, effective immediately.

Editor-in-Chief, Metabolism: Christos S. Mantzoros, MD DSc FACP FACE

Christos Mantzoros is clinical research lead at the Department of
Endocrinology, Diabetes and Metabolism at Beth Israel Deaconess Medical
Center, Boston, and associate professor of medicine at Harvard Medical
School. He replaces James B. Field, who retires as Editor of Metabolism.
Professor Mantzoros' research involves the discovery and elucidation of novel
molecules central in the pathogenesis of diabetes, obesity, and related
diseases. The Mantzoros group employs a wide range of basic, translational,
and clinical approaches in this aim.

Editor-in-Chief, Primary Care Diabetes: Jaakko Tuomilehto, MD, PhD

Jaakko Tuomilehto succeeds Rhys Williams as Editor-in-Chief of Primary
Care Diabetes. Professor Tuomilehto, University of Helsinki, has a broad and
extensive experience in clinical epidemiology and genetic epidemiology of
type 1 and type 2 diabetes. He is also an experienced coordinator of national
studies in Finland and international collaborative studies, with a publishing
record in excess of 900 papers comprising several landmark studies. Primary
Care Diabetes is the official journal of Primary Care Diabetes Europe.

Editor-in-Chief, PLEFA: Richard P. Bazinet, PhD

Richard P Bazinet takes over the editorship of PLEFA (Prostaglandins,
Leukotrienes and Essential Fatty Acids), from Mehar Manku, who remains as
Editor Emeritus. Dr Bazinet, a former Associate Editor, is a researcher at
the Faculty of Medicine, University of Toronto, and works to identify the
mechanisms that regulate brain lipid metabolism and the role of brain lipid
metabolism in the pathogenesis of neurodegenerative diseases and
neuropsychiatric disorders. PLEFA is the official journal of the
International Society for the Study of Fatty Acids and Lipids.

About Metabolism

This eminent journal (
www.elsevier.com/wps/find/journaldescription.cws_home/623319/descripti
on#description) is regarded by clinicians and researchers alike as an
authoritative source of practical information on metabolic processes and
diseases in the areas of nutrition, genetics, dystrophies, diabetes and gout.
Reviews and surveys on the status of research and practice in specific
metabolic disorders are featured.

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

About Primary Care Diabetes

The journal (
www.elsevier.com/wps/find/journaldescription.cws_home/710796/descripti
on#description) publishes original research articles and high quality reviews
in the fields of clinical care, diabetes education, nutrition, health
services, psychosocial research and epidemiology and other areas as far as is
relevant for diabetology in a primary-care setting. The purpose of the
journal is to encourage interdisciplinary research and discussion between all
those who are involved in primary diabetes care on an international level.
The Journal also publishes news and articles concerning the policies and
activities of Primary Care Diabetes Europe and reflects the society's aim of
improving the care for people with diabetes mellitus within the primary-care
setting.

About Prostaglandins, Leukotrienes & Essential Fatty Acids (PLEFA)
(www.elsevier.com/wps/find/journaldescription.cws_home/623065/descript
ion#description) The role of lipids, including essential fatty acids and
their prostaglandin, leukotriene and other derivatives, is now evident in
almost all areas of biomedical science. Cell membrane behaviour and cell
signalling in all tissues are highly dependent on the lipid constituents of
cells. Prostaglandins, Leukotrienes and Essential Fatty Acids aims to cover
all aspects of the roles of lipids in cellular, organ and whole organism
function, and places a particular emphasis on human studies. Papers
concerning all medical specialties are published. Much of the material is
particularly relevant to the development of novel treatments for disease.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect (www.sciencedirect.com), Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult
(www.nursingconsult.com), which enhance the productivity of science
and health professionals, and the SciVal suite (www.scival.com) and
MEDai's Pinpoint Review (www.medai.com), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Andrew Miller
    Executive Publisher, Elsevier
    Tel.: +44(0)1865-843823
    andrew.miller@elsevier.com

Andrew Miller, Executive Publisher, Elsevier, Tel.: +44(0)1865-843823, andrew.miller at elsevier.com